fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Examining when to get off meds for multiple sclerosis

Written by | 2 Aug 2023

Researchers at the Population Health Outcomes and Pharmacoepidemiology Education and Research Center (P-HOPER Center) at the University of Houston College of Pharmacy are examining when older patients with… read more.

Study finds ‘startling’ levels of hidden mental health symptoms among people living with long term autoimmune diseases

Written by | 27 Jul 2023

More than half of patients with auto-immune conditions experience mental health conditions such as depression or anxiety, yet the majority are rarely or never asked in clinic about… read more.

Device for treating challenging bone fractures cleared by FDA

Written by | 26 Jul 2023

A new system for fixing bone fractures, called the Bone Bolt System, has been approved for market by the U.S. Food and Drug Administration (FDA), the University of… read more.

Joint disease: New therapeutic approach for osteoarthritis discovered

Written by | 4 Jul 2023

Osteoarthritis was long considered to be the result of wear and tear in advanced age. In the meantime, more and more studies are linking the degradation of articular… read more.

Managing anxiety and depression in arthritis

Written by | 5 Jun 2023

Anxiety and depression are the mental health issues most commonly associated with inflammatory arthritis, and it is well-established that there is a link between mental health issues and… read more.

A commonly used tool is suboptimal in predicting osteoporosis fracture risk in younger post-menopausal women

Written by | 24 May 2023

The commonly used Fracture Risk Assessment Tool (FRAX), which includes self-identified race and ethnicity information, and the Osteoporosis Self-Assessment Tool (OST), which does not, had suboptimal performance in… read more.

Patients with rheumatic and musculoskeletal conditions vulnerable to long term opioid use

Written by | 19 May 2023

Patients with rheumatic and musculoskeletal conditions are vulnerable to long term opioid use, with up to 1 in 3 of those with rheumatoid arthritis or fibromyalgia, who take… read more.

A sharp increase in the price of the gout drug colchicine led to lower use and poorer disease control, UCLA research suggests

Written by | 11 May 2023

Due to a policy decision in 2010 by the U.S. Food and Drug Administration (FDA), the price of a prescription for the therapeutic gout drug colchicine increased nearly… read more.

Study provides genetic evidence on new osteoporosis drug heart attack risk

Written by | 6 May 2023

New research highlights potential safety concerns around women taking romosozumab, a new anti-osteoporosis drug available on the NHS. The University of Bristol-led study, published in Arthritis & Rheumatology, analysed… read more.

New study questions the efficacy of many osteoarthritis treatments

Written by | 29 Apr 2023

Recruiting osteoarthritis patients with a lot of pain to clinical studies, may give incorrect results if the researcher does account for the natural variation in pain that occurs…. read more.

New guideline introduces recommendations for optimal timing of elective hip or knee arthroplasty

Written by | 18 Mar 2023

The American College of Rheumatology (ACR) and the American Association of Hip and Knee Surgeons (AAHKS) released a summary of its new guideline titled “the Optimal Timing of… read more.

New breakthrough in the treatment of rheumatoid arthritis

Written by | 3 Feb 2023

A research team, led by Professor Sung Ho Park in the Department of Biological Sciences at UNIST announced the results of a study on osteoblasts that damage joint bones… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.